'Parkinson's disease (PD) is the second most common neurodegenerative disease, ranking lower only than Alzheimer Parkinsons disease, and affects more than 10 million people worldwide. The average prevalence of PD in the Han population in China is ~3.9‰ of those ≥50 years of age. It is estimated that the number of Chinese patients with PD will increase to 4.94 million by 2030, accounting for half of PD patients worldwide.'- Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study.
Join us for a valuable update on New Advance Treatments by a local expert.
Date: Thursday 18th April 2024
Venue: Novotel Glen Waverley
Time 6.30pm for 7pm start
Speaker: Dr Mina Ghaly (General Neurologist & Movement disorder specialist)
Proudly sponsored by Metronic
Australian Chinese Medical Association of Victoria and ACMAV Health Promotion Trust
Tel 03 9899 6380Fax 03 9899 6389office@acmav.orgABN 34 112 890 590
Postal AddressPO Box 2064Hotham HillVIC 3051Australia